These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28807510)

  • 1. Angina after percutaneous coronary intervention: The need for precision medicine.
    Niccoli G; Montone RA; Lanza GA; Crea F
    Int J Cardiol; 2017 Dec; 248():14-19. PubMed ID: 28807510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms and diagnostic evaluation of persistent or recurrent angina following percutaneous coronary revascularization.
    Crea F; Bairey Merz CN; Beltrame JF; Berry C; Camici PG; Kaski JC; Ong P; Pepine CJ; Sechtem U; Shimokawa H
    Eur Heart J; 2019 Aug; 40(29):2455-2462. PubMed ID: 30608528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of endothelial dysfunction in determining angina after percutaneous coronary intervention: Learning from pathophysiology to optimize treatment.
    Mangiacapra F; Del Buono MG; Abbate A; Gori T; Barbato E; Montone RA; Crea F; Niccoli G
    Prog Cardiovasc Dis; 2020; 63(3):233-242. PubMed ID: 32061633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent or Recurrent Angina Following Percutaneous Coronary Revascularization.
    Ajmal M; Chatterjee A; Acharya D
    Curr Cardiol Rep; 2022 Dec; 24(12):1837-1848. PubMed ID: 36287295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermodilutional Confirmation of Coronary Microvascular Dysfunction in Patients With Recurrent Angina After Successful Percutaneous Coronary Intervention.
    Li Y; Yang D; Lu L; Wu D; Yao J; Hu X; Long M; Luo C; Du Z
    Can J Cardiol; 2015 Aug; 31(8):989-97. PubMed ID: 26088108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angina and associated healthcare costs following percutaneous coronary intervention: A real-world analysis from a multi-payer database.
    Ben-Yehuda O; Kazi DS; Bonafede M; Wade SW; Machacz SF; Stephens LA; Hlatky MA; Hernandez JB
    Catheter Cardiovasc Interv; 2016 Dec; 88(7):1017-1024. PubMed ID: 26774951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of Angina Pectoris After Percutaneous Coronary Intervention and the Effect of Metallic Stent Type.
    Gaglia MA; Torguson R; Lipinski MJ; Gai J; Koifman E; Kiramijyan S; Negi S; Rogers T; Steinvil A; Suddath WO; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2016 Feb; 117(4):526-531. PubMed ID: 26739394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angina Severity, Depression, and Response to Percutaneous Revascularization in Patients With Chronic Total Occlusion of Coronary Arteries.
    Bruckel JT; Jaffer FA; O'Brien C; Stone L; Pomerantsev E; Yeh RW
    J Invasive Cardiol; 2016 Feb; 28(2):44-51. PubMed ID: 26477043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary artery bypass graft surgery versus percutaneous coronary intervention with drug-eluting stents for left main coronary artery disease: A meta-analysis of randomized trials.
    Putzu A; Gallo M; Martino EA; Ferrari E; Pedrazzini G; Moccetti T; Cassina T
    Int J Cardiol; 2017 Aug; 241():142-148. PubMed ID: 28438354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Ranolazine on Angina and Quality of Life After Percutaneous Coronary Intervention With Incomplete Revascularization: Results From the Ranolazine for Incomplete Vessel Revascularization (RIVER-PCI) Trial.
    Alexander KP; Weisz G; Prather K; James S; Mark DB; Anstrom KJ; Davidson-Ray L; Witkowski A; Mulkay AJ; Osmukhina A; Farzaneh-Far R; Ben-Yehuda O; Stone GW; Ohman EM
    Circulation; 2016 Jan; 133(1):39-47. PubMed ID: 26555329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-percutaneous coronary intervention angina: From physiopathological mechanisms to individualized treatment.
    De Luca L; Rosano GMC; Spoletini I
    Cardiol J; 2022; 29(5):850-857. PubMed ID: 33843042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of coronary microvascular dysfunction with restenosis of left anterior descending coronary artery disease treated by percutaneous intervention.
    De Vita A; Milo M; Sestito A; Lamendola P; Lanza GA; Crea F
    Int J Cardiol; 2016 Sep; 219():322-5. PubMed ID: 27344133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Native coronary disease progression exceeds failed revascularization as cause of angina after five years in the Bypass Angioplasty Revascularization Investigation (BARI).
    Alderman EL; Kip KE; Whitlow PL; Bashore T; Fortin D; Bourassa MG; Lesperance J; Schwartz L; Stadius M;
    J Am Coll Cardiol; 2004 Aug; 44(4):766-74. PubMed ID: 15312856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis and disease progression in patients under 50 years old undergoing PCI: the CRAGS (Coronary aRtery diseAse in younG adultS) study.
    Lautamäki A; Airaksinen KE; Kiviniemi T; Vinco G; Ribichini F; Gunn J; Anttila V; Heikkinen J; Korpilahti K; Karjalainen P; Kajander O; Eskola M; Ilveskoski E; Axelsson T; Gudbjartsson T; Jeppsson A; Biancari F
    Atherosclerosis; 2014 Aug; 235(2):483-7. PubMed ID: 24953487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Shenzhu Guanxin Recipe () on patients with angina pectoris after percutaneous coronary intervention: A prospective, randomized controlled trial.
    Xu DP; Wu HL; Lan TH; Wang X; Sheng XG; Lin Y; Li S; Zheng CY
    Chin J Integr Med; 2015 Jun; 21(6):408-16. PubMed ID: 26063318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous Coronary Intervention of Coronary Chronic Total Occlusions Improves Peak Oxygen Uptake During Cardiopulmonary Exercise Testing.
    Abdullah SM; Hastings JL; Amsavelu S; Garcia-Morales F; Hendrix F; Karatasakis A; Danek BA; Karacsonyi J; Rangan BV; Roesle M; Khalili H; Banerjee S; Brilakis ES
    J Invasive Cardiol; 2017 Mar; 29(3):83-91. PubMed ID: 28255103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of angina resolution after percutaneous coronary intervention in stable coronary artery disease.
    Verreault-Julien L; Bhatt DL; Jung RG; Di Santo P; Simard T; Avram R; Hibbert B
    Coron Artery Dis; 2022 Mar; 33(2):98-104. PubMed ID: 34148973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent angina: the Araba Phoenix of cardiology.
    Marzilli M; Huqi A; Morrone D
    Am J Cardiovasc Drugs; 2010; 10 Suppl 1():27-32. PubMed ID: 21391731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of definite stent thrombosis or in-stent restenosis after drug-eluting stent implantation for treatment of coronary in-stent restenosis: from Western Denmark Heart Registry.
    Jensen JK; Jensen LO; Terkelsen CJ; Lassen JF; Tilsted HH; Hansen KN; Maeng M; Thuesen L; Thayssen P
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):260-5. PubMed ID: 22511512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect on periprocedural myocardial infarction of intra-coronary nicorandil prior to percutaneous coronary intervention in stable and unstable angina.
    Hwang J; Lee HC; Kim BW; Yang MJ; Park JS; Park JH; Lee HW; Oh J; Choi JH; Cha KS; Hong TJ; Song S; Kim SP
    J Cardiol; 2013 Aug; 62(2):77-81. PubMed ID: 23731922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.